Comprehensive review of the BIO ecosystem: What other potential targets are worth paying attention to?
On December 23, Binance announced that Binance Launchpool will launch the 63rd project BIO Protocol (BIO), and will open trading pairs such as BIO/USDT and BIO/BNB on January 3, 2025. According to the Binance announcement, the total supply of BIO Protocol Genesis टोकनs is 3,320,000,000, and the initial spot circulation when Binance listed the token is 1,296,529,168, accounting for about 39.05% of the total supply of Genesis Tokens. Among them, 56% of BIO tokens will be allocated to the ecosystem and community, 25.4% to early contributors, and 18.6% to early supporters.
Since Binance Labs announced its investment in BIO Protocol, the DeSci market has been rekindled, and related concept tokens such as VITA, GROW, and RSC have all risen sharply. After the news of Binance Launchpool came out, the recently popular ecological meme coins also rose rapidly, with RIF rising by more than 40% in a short period of time, URO rising by more than 35% in a short period of time, and DRUGS rising by more than 150% in a short period of time. In addition, old-fashioned DeSci such as VITA and RSC have also begun to respond to the market.
In this article, BlockBeats comprehensively sorts out the current BIO ecosystem and potential targets related to the DeSci concept. From DAO to NFT to meme coins, there is actually no shortage of hype opportunities in the DeSci field.
BIO Ecosystem DeSci DAO
BIO is a biological DAO network, each of which focuses on developing research and products in a specific scientific field. Currently, the BIO network consists of eight different scientific communities focusing on longevity, womens health, neurodegenerative diseases, and synthetic biology. This article will not go into detail about the background and mechanism of BIO Protocol.
Initial DeSci DAO
The initial DeSci DAO was established before the BIO Protocol was separated from Molecule. There are currently 7 DeSci DAO organizations. After the establishment of the BIO Protocol, these DAO organizations were first incorporated into the BIO network. In the previous BIO Genesis Event, users also had to exchange BIO tokens by using the tokens of these DAO organizations, so these DAO tokens are also part of the BIO network assets.
VitaDAO: With over $5 million in funding in the field of longevity science, it is a DeSci decentralized science organization backed by Pfizer Ventures and Balaji Srinivasan, in collaboration with Newcastle University. It is worth noting that VitaDAO is the oldest of the old, the first DeSci DAO of Molecule, the originator of DeSci and the mother of BIO Protocol, focusing on research in the field of longevity. The current BIO Protocol Association is also a Swiss non-profit organization founded by key members of VitaDAO.
HairDAO: Targets hair loss; DAO has patents and consumer product Follicool.
CerebrumDAO: Boosting brain health, raised over $1.5 million, inked a deal with Fission Pharma to address mitochondrial dysfunction in neurodegenerative diseases.
ValleyDAO: Focused on synthetic biology, raised over $2 million and is working with Imperial College London.
AthenaDAO: Promotes womens health RD, provides $500,000 in funding for translational research, and has 14 intellectual property transactions pending.
CryoDAO: Advancing the field of cryogenics, raising over $3 million for the field, and establishing projects with Oxford Cryogenics and Advanced Neurobiosciences.
PsyDAO: Focused on psychedelic drugs, it launched OPSY, a new platform that leverages psychedelic drug trials and data.
The First Launchpad DAOs
BIO Protocol recently announced the first batch of Launchpad DAOs after its launch. These DAOs were launched through the Launchpad mechanism of the BIO platform. Among them, the first DAO to conduct a token auction was Quantum Biology DAO. The auction ended on December 17. The bidding was very hot during the period, and the starting price once exceeded the original bid by more than 10 times.
Long COVID Labs: Accelerating the cure of more than 100 million Long COVID patients. Founded by Rohan Dixit, a former Stanford University neuroscientist, healthcare entrepreneur and Long COVID survivor.
Quantum Biology DAO: Building quantum microscopes to advance biological research. Founders are Clarice D. Aiello (PhD from MIT, world-leading quantum biology scientist) and Geoff Anders (Executive Director of Leverage Research).
Curetopia (Rare Diseases): Addressing the $10K+ rare disease space by uniting families and patient communities. Founded by Ethan Perlstein, a Harvard PhD, entrepreneur, and Y-Combinator alumnus.
BIO meme AI DAO
In addition to serious scientific research DAO organizations, the BIO team and community have also conducted interesting DeSci experiments outside of DeSci DAO and successfully brought a lot of attention to the DeSci field.
RIF/URO
Pump.Science is a meme token issuance platform launched by BIO Protocol at this years Token 2049 Solana Breakpoint Conference. Players can purchase meme tokens representing drugs and participate in the prediction of drug effects and the trading of experimental data. The surge in RIF/URO after DEVCON Bangkok was also the direct fuse that ignited the DeSci field. For a long time in the past, it was regarded by the market as the hype leader in the DeSci field.
संबंधित पठन:
Desci leader also makes some new moves, can Pump.science play the biological science meme well?
DRUGS
DRUGS (Big Pharmai), also known as Little BIO, is the son of the BIO Protocol ecosystem. DRUGS aims to subvert the monopoly business model of traditional large medical drug companies. Since its inception, the project has received widespread support from the BIO ecosystem, including Pump Science, other BIO-related DeSci DAOs, and BIO co-founder Paul himself.
संबंधित पठन: DRUGS 500-fold wealth creation myth sets off a wave of new listings on daos.fun
GIRLE/BABY
GIRLE and BABY are AI DAO and meme tokens issued by AthenaDAO in the BIO ecosystem on the Solana DAOs.fun platform and the Base chain respectively. Both support scientific research in the field of female fertility.
Among them, GIRLE aims to empower the future of fertility with tokens through AI and Web3. The team is currently conducting experiments related to peptide cell repair, testing the effects of peptides on cells, and will soon launch related experimental tokens. On its official website, you can also see other token holdings in the DAO treasury.
BIO Ecological IPT
IPTs are intellectual property tokens pioneered by the Molecule Catalyst platform that represent partial governance rights over generated scientific IP. These tokens give holders the opportunity to directly participate in the development, decision-making, and future direction of research. Each BioDAO typically holds a portfolio of IP tokens that represent intellectual property related to the BioDAOs specific area of scientific research. Currently, the most recognized IPTs are VitaRNA and VITA-FAST, which are developed and owned by VitaDAO.
IPT VitaRNA VITA-FAST
VitaRNA is an IPT of Artan Bio, a gene therapy program that raised over $300,000. Artan Bio is exploring the promising field of gene therapies that help address genetic factors associated with aging. The companys approach aims to develop therapeutic candidates that may inhibit mutations that cause aging. Artan Bio is led by two entrepreneurs who have previously advanced drug development platforms into human clinical trials.
VITA-FAST is an IPT from Viktor Korolchuk’s lab, which also successfully raised over $300,000. VITA-FAST focuses on the research of drugs that enhance autophagy, which is the natural “garbage disposal” built into our body cells that eliminates unnecessary protein accumulation.
OVARIA
OVARIA is an IPT launched by AthenaDAO in partnership with Gero, a biotech company using artificial intelligence for target and drug discovery, with the goal of revolutionizing the treatment landscape for ovarian aging, providing therapeutic potential in areas that are currently limited. AthenaDAO will use their platform to identify up to 10 new targets for ovarian aging, with the potential to delay menopause and reduce its health-related consequences.
Competitors Related Memes
In addition to BIO-related targets, the ecological enthusiasm has also expanded to other areas of DeSci.
आरएससी
Research Hub is a DeSci project founded by Coinbase CEO Brian Armstrong, whose mission is to accelerate the pace of scientific research. By making modern mobile and web applications, people can conduct scientific research in a more efficient way.
Within the ResearchHub platform, research papers are stored by research area and grouped in “hubs.” Personal hubs will essentially act as live journals within a focus area, with highly voted posts (i.e. papers and their associated abstracts and discussions) moved to the top of each hub.
Scihub
Scihub is inspired by Sci-hub, the worlds largest free paper download center. Due to open source, it faces legal issues and the platform is maintained only by donations. 0x AA (@0x AA_Science) is the top 1 holder of the token, currently holding 22% of the total tokens. He said that he would donate 20% of the tokens to the operator of SciHub to show his support for its cause and platform development.
Currently, BIO Protocol has announced its 2025 roadmap, including:
The BIO token will undergo a TGE on the Ethereum mainnet on January 3;
BIO tokens will be available on Solana and Base networks;
New BioDAO launched;
BIO/BioDAO liquidity pool;
The new BIO Launchpad is now live.
With the listing of BIO tokens on Binance, the DeSci field may usher in a new wave of enthusiasm.
This article is sourced from the internet: Comprehensive review of the BIO ecosystem: What other potential targets are worth paying attention to?
Related: The prices of ENA and HYPE continue to soar. What is the logic behind them?
Tale of Two Tokens: What Ethena and HyperLiquid Teach Us Original article by Diogenes Casares, Crypto Kol Original translation: zhouzhou, BlockBeats Editors note: HyperLiquid and Ethena have both successfully executed their respective product visions despite using different financing and token strategies. HyperLiquid focuses on decentralized derivatives, while Ethena has rapidly grown into a leading stablecoin protocol. Both have made decisions that are in line with product development by understanding user needs and dynamically adjusting strategies. The key to success is to guide decisions based on a clear vision and belief, rather than a one size fits all approach. The following is the original content (for easier reading and understanding, the original content has been reorganized): HyperLiquid became a top 20 token (if FDV is counted) within weeks of its initial…